The Latest in Journal of Clinical Outcomes Management

Medical boards change or consider amending mental health-related licensing questions

September 30, 2019

FDA adds diabetic kidney disease, heart failure indications to canagliflozin

September 30, 2019

Immunotherapy duo extends survival in first line for advanced NSCLC

September 29, 2019

Cardiotoxicity after checkpoint inhibitor treatment seen early, linked to elevated biomarkers

September 29, 2019

Adjuvant radiotherapy no better than salvage post prostatectomy

September 28, 2019

Patient-reported outcomes are here to stay

September 27, 2019

Cancer drug prices higher in U.S. than Europe; don’t correlate with clinical benefit

September 27, 2019

Tranexamic acid does not increase complications in high-risk joint replacement surgery patients

September 26, 2019

Surgery

Acting FDA commissioner issues remarks on ENDS, vaping illnesses

September 25, 2019

Pulmonology

FDA approves first live vaccine for smallpox, monkeypox prevention

September 25, 2019

RISE analyses highlight further youth vs. adult T2D differences

September 25, 2019

OS benefit with pembrolizumab endures long-term in advanced NSCLC

September 24, 2019

U.S. adults eating fewer carbs, more protein and fat

September 24, 2019

Obesity

PACIFIC: Patterns of lung cancer progression suggest role for local ablative therapy

September 23, 2019

Vitamin D does not improve bone density, structure in healthy patients

September 23, 2019